Clinical Trial Update: An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis [Phase 4]

View source ↗

Summary

An early phase 4 trial update assessing mycophenolate mofetil for fibrotic hypersensitivity pneumonitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypersensitivity Pneumonitis

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Hypersensitivity Pneumonitis | Phase 4 | Status: UNKNOWN